权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Matrices for optimal endogenous progenitor cell recruitment and function

最佳内源祖细胞招募和功能的基质

基本信息

批准号：
9206999
负责人：
WILLIAM L. MURPHY
金额：
$ 18.49万
依托单位：
UNIVERSITY OF WISCONSIN-MADISON
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-02-01 至 2017-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9206999
关键词：
Angiogenic Proteins Animals Biochemical Biocompatible Materials Biological Biological Assay Biophysics Blood Blood Circulation Cardiovascular Diseases Cell Adhesion Cell physiology Cells Chemicals Chemistry Clinical Coronary Arteriosclerosis Cues Defect Diabetes Mellitus Diabetic wound Disease Endothelial Cells Extracellular Matrix Fluorescence Microscopy Formulation Generic Drugs Growth Factor Hindlimb Human Hydrogels Implant In Vitro Invaded Ischemia Low Prevalence Mediating Modeling Mus Myocardial Infarction Myocardial Ischemia Outcome Peptides Property Recruitment Activity Regenerative Medicine Research Scheme Series Site Skin Spottings Stem cells Stroke Therapeutic Time Tissue Engineering Tissues Treatment Efficacy Vascular blood supply Wound Healing angiogenesis biophysical properties bone cell type chemokine clinical application controlled release design diabetic wound healing dosage functional outcomes healing improved in vivo innovation interest mouse model neovascularization novel peptidomimetics programs public health relevance regenerative tissue regeneration

项目摘要

DESCRIPTION: We propose an approach to use synthetic biomaterial arrays to recruit functional circulating angiogenic cells (CACs), and thereby enhance neovascularization. There is a critical need to: i) systematically explore the biomaterials-associated factors that may be critical to endogenous CAC recruitment, and ii) efficiently discover optimal biomaterials for CAC recruitment and function. We will use an enhanced throughput approach to discover optimal hydrogels for CAC recruitment and sustained function. We propose to use these biomaterials to leverage circulating CACs and enhance angiogenesis in vivo. Specific Aim 1 will characterize biomaterial parameters that control hCAC invasion and pro-angiogenic function. We hypothesize that the concentration of cell adhesion peptides, biomaterial stiffness, and the identity, dosage, and release rate of soluble chemokines will each significantly influence selective hCAC recruitment and pro-angiogenic function. Specific Aim 2 will use a novel in vivo hydrogel array to screen optimal biomaterial parameters for hCAC recruitment and hCAC- mediated angiogenesis in a mouse model. We hypothesize that hydrogel arrays implanted into a mouse skin- fold chamber will identify formulations that will improve functional outcome in a subsequent model of hindlimb ischemia. The proposed studies are Significant, as they will enable identification of biomaterials that enhance clinical use of endogenous CACs to improve angiogenesis. Tissue regeneration is limited by poor blood supply, and many disease states (e.g. diabetes) are characterized by a lack of sufficient vasculature. Therefore, a material approach to leverage endogenous CACs could have a substantial impact on tissue regeneration approaches. The proposed studies are Innovative, as they use chemically-defined hydrogel arrays to discover biomaterial cues for selective CAC recruitment and function, both in vitro and in vivo. The arrays are composed of biomaterials that are highly adaptable, such that the biochemical and biophysical properties of array spots can be broadly varied. These studies will provide a basis for a larger research program to elucidate the mechanisms of endogenous cell recruitment and CAC-mediated angiogenesis in vitro and in vivo.